Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities

Bone

Volumn 21, Issue 3, 1997, Pages 217-223

  Rosen, C J ^a   Dimai, H P ^b   Vereault, D ^a   Donahue, L R ^c   Beamer, W G ^c   Farley, J ^b   Linkhart, S ^b   Linkhart, T ^b   Mohan, S ^b   Baylink, D J ^b  

^a ST JOSEPH HOSPITAL   (United States)

^b Jerry L Pettis VA Hospital   (United States)

^c JACKSON LABORATORY   (United States)

Author keywords

Femoral bone density; Insulin like growth factors

Indexed keywords

ALKALINE PHOSPHATASE; SOMATOMEDIN C;

AGE; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BONE DENSITY; BONE MASS; BONE MINERAL; CALVARIA; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; FEMUR; INBRED STRAIN; MOUSE; NONHUMAN; RADIOIMMUNOASSAY; STRAIN DIFFERENCE; TIBIA; TISSUE CULTURE; VARIANCE;

AGING; ALKALINE PHOSPHATASE; ANIMALS; BONE DENSITY; FEMALE; FEMUR; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; RADIOIMMUNOASSAY;

EID: 0030765081     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(97)00143-9     Document Type: Article

References (21)

1. Baylink, D. J., Finkelman, R. D., and Mohan, S. Growth factors to stimulate bone formation. J Bone Miner Res 8(Suppl.):S565-S572; 1993.
2. Beamer, W. G., Donahue, L. R., Rosen, C. J., and Baylink, D. J. Genetic variability in adult bone density among inbred strains of mice, Bone 18:397-403; 1996.
3. Bennett, A. E., Heinz, W. W., Riggs, B. L., and Hintz, R. IGF-I and II: Aging and bone density in women. J Clin Endocrinol Metab 59:701-704; 1984.
4. Bing-You, R. G., Denis, M. C., and Rosen, C. J. Low bone mineral density in adults with previous hypothalamic-pituitary tumors: Correlations with serum GH responses to GHRH, IGF-I and IGFBP-3. Calcif Tissue Int 52:183-187; 1993.
5. Boonen, S., Lesaffre, E., Dequeker, J., Aerssens, J., Nijs, J., Pelemans, W., and Bouillon, R. Relationship between basal IGF-I and femoral bone density in women aged over 70 years: Potential implications for the prevention of age-related bone loss. J Am Geriatr Soc 44:1301-1306; 1996.
6. Brier, R. H., Ballaher, B. W., and Gluckman, P. D. Radioimmunoassay for IGF-I: Solutions to some potential problems and pitfalls. J Endocrinol 128: 347-357; 1991.
7. Donahue, L. R. and Beamer, W. G. Growth hormone deficiency in little mice results in aberrant body composition, reduced IGF-I and IGFBP-3 but does not affect IGFBP-2, -1, or -4. J Endocrinol 136:91-104; 1993.
8. Donahue, L. R., Beamer, W. G., and Rosen, C. J. Parathyroid hormone (PTH) improves bone density in mice with growth hormone (GH) deficiency and insulin-like growth factor (IGF-I) deficiency. J Bone Miner Res 10(Suppl); 1995.
9. Farley, J. R., Hill, S. L., Tanner, M. A., and Wegedal, J. E. Specific activity of skeletal alkaline phosphatase in human osteoblast like cells is regulated by phosphate, phosphate esters and phosphate analogs and release of alkaline phosphatase activity is inversely regulated by calcium. J Bone Miner Res 9:497-508; 1994.
10. Godfrey, P., Rahal, J. O., Beamer, W. G., Copeland, N. G., Jenkins, N. A., and Mayo, K. E. GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet 4:227-232; 1993.
11. Grogean, T., Vereault, D., Millard, P. S., Kiel, D., MacLean, D., Orwoll, E., Greenspan, S., and Rosen, C. J. A comparative analysis of methods to measure IGF-I in human serum. Endocrinol Metab 4:109-114; 1997.
12. Hayden, J. M., Mohan, S., and Baylink, D. J. The insulin-like growth factor system and the coupling of formation to resortion. Bone 17(Suppl.):93S-98S: 1995.
13. Jorgensen, J. O. L., Thuesen, L., Ingemann-Hansen, T., Pedersen, S. A., Jorgensen, J. U., Skakkebaek, N. E. S., and Christiansen, J. S. Beneficial effects of GH treatment in GH deficient adults. Lancet i:1221-1225; 1989.
14. Linkhart, T. A. and Mohan, S. PTH stimulates release of IGF-I and IGF-II from neonatal mouse calvaria in organ culture. Endocrinology 125:1484-1491; 1989.
15. Ljunghall, S., Johansson, A. G., Bornane, P., Kampe, O., Lindh, E., and Karlsson, F. A. Low plasma levels of IGF-I in male patients with idiopathic osteoporosis. J Intern Med 232:59-64; 1992.
16. Mohan, S., and Baylink, D. J. Development of a simple valid method for the complete removal of IGF-binding proteins from IGFs in human serum and other biological fluids: Comparison with acid-ethanol treatment and C18 Sep-Pak separation. J Clin Endocrinol Metab 80:637-647; 1995.
17. Nicholas, V., Prewett, A., Bettica, P., Mohan, S., Finkleman, R. D., Baylink, D. J., and Farley, J. R. Age related decreases in IGF-I and transforming growth factor-β in femoral cortical bone from both men and women: Implications for bone loss in aging. J Clin Endocrinol Metab 78:1011-1016; 1994.
18. Reed, B. Y., Zerwekh, J. E., Sakhaee, K., Breslau, N. A., Gottschalk, F., and Pak, C. Y. C. Serum IGF-I is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res 10:1218-1224; 1995.
19. Rosen, C. J., Donahue, L. R., and Hunter, S. J. Insulin-like growth factors and bone: The osteoporosis connection. Proc Soc Exp Biol Med 206:83-102; 1994.
20. Sinha, Y. N., Salocks, C. B., and Vanderlaan, W, P. Prolactin and growth hormone levels in different inbred strains of mice: Patterns in association with estrous cycle, time of day and perphenazine stimulation. Endocrinology 97: 1112-1122; 1975.
21. Sinha, Y. N., Vlahakis, G., and Vanlerlaan, W. P. Serum, pituitary and urine concentrations for prolactin and growth hormone in eight strains of mice with varying incidence of mammary tumors. Int J Cancer 24:430-437; 1979.